Caigan Du, PhD

 

Assistant Professor
Department of Urologic Sciences

phone: 604-875-4111 x63793

caigan.du(at)ubc.ca

PubMed Publication Listing

 

Kidney Rejection

Kidney transplantation is an effective therapy for patients with end-stage of kidney disease which can significantly improve quality and quantity of life. However, long-term survival of kidney transplants is a major challenge in clinic.

My laboratory uses animal models, kidney cell cultures, molecular biology, and biochemistry techniques to study kidney transplant rejection in an attempt to improve transplant survival. Our research focuses on three areas:

  1. The mechanism and regulation of renal tubular epithelial cell death (apoptosis and necrosis), survival and epithelial-mesenchymal transition (renal fibrosis).

  2. The role of interaction cascade of resident renal tubular epithelial cells (e.g. up-regulation of IL-6, TGF-beta, and release of IL-16) with leukocyte infiltrates in kidney transplant rejection.
     
  3. The development of immunosuppressive drug therapy using small molecular compounds for organ transplant rejection.

 

Education

PhD - Biochemistry - University of Wales Swansea, UK

MPhil - Biology - University of Wales Swansea, UK

BSc - Biology - Jiangxi University, China

Blood Donors

click here for info

 

Events


June 28, 2010 - ImmunoVancouver 2010 Conference.  Keynote Speaker: Dr. Joan Goverman, University of Washington

Latest News

July 2010 Newsletter

March 15, 2010 - IIRC trainees receive VCHRI awards - Judith Silverman (Reiner Lab), Abdi Ghaffari (Ghahary Lab), Dirk Lange (Chew Lab), and Adele Wang (Levings Lab)

Sept 17, 2009 - Provincial Cuts to Research that hit the IIRC reported on in the Vancouver Sun